Optimized production of syphilis antigens

梅毒抗原的优化生产

• 批准号: 499035-2016
• 负责人: Cameron, Caroline
• 金额: $ 1.82万
• 依托单位: University of Victoria
• 依托单位国家: 加拿大
• 项目类别: Engage Grants Program
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=607152
• 关键词: Optimized; production; syphilis; antigens

This NSERC Engage proposal represents an exciting collaborative opportunity between a leading Canadian biotechnology company that specializes in diagnostic platform development (bioLytical Laboratories) and a Canadian university-based research team, located at the University of Victoria, with novel expertise in syphilis diagnostic antigen discovery and development. The proposal focuses upon the adaptation of previously identified, highly sensitive and specific syphilis diagnostic antigens to the diagnostic platform utilized by bioLytical, and the subsequent analysis of the performance of these proteins in bioLytical's novel platform.

这项NSERC Engage提案代表了一家领先的加拿大生物技术公司（bioLytical Laboratories）和一个位于维多利亚大学的加拿大大学研究团队之间令人兴奋的合作机会，该公司专门从事诊断平台开发，在梅毒诊断抗原发现和开发方面具有新颖的专业知识。该提案的重点是将先前鉴定的高灵敏度和特异性梅毒诊断抗原适应bioLytical使用的诊断平台，以及随后分析这些蛋白质在bioLytical新平台中的性能。